Highlights
- HMC Capital (ASX:HMC) could see a major healthcare-property overhang ease after a Calvary-led consortium secured Healthscope's hospital operations.
- HMC-managed HealthCo Healthcare & Wellness REIT and an associated unlisted fund own 11 hospitals previously leased to Healthscope.
- Healthscope's receivership disrupted rental income and affected HealthCo's FY2026 funds from operations.
- Lease execution, regulatory approvals and restoration of rental income remain the next important milestones.
HMC Capital (ASX:HMC) is entering a potentially important phase for its healthcare property platform after a Calvary Health Care-led consortium was selected to take over Healthscope's hospital operations.
The outcome matters because HealthCo Healthcare & Wellness REIT and an associated unlisted healthcare fund managed by HMC own a portfolio of hospitals previously leased to Healthscope. Resolving the identity of the hospital operator could help reduce uncertainty around rental income and asset performance after an extended period of disruption.
Recent Development
In mid-September 2026, a Calvary Health Care-led consortium was confirmed as the successful party to take over Healthscope's hospital operations following a receivership process that began in 2025.
Healthscope's lenders had previously supported the transfer of operations at 10 hospitals to the consortium, helping clear an important step in the restructuring process.
HMC Capital (ASX:HMC) is connected to the outcome through its managed healthcare property vehicles. HealthCo Healthcare & Wellness REIT and an associated unlisted fund together own 11 hospitals that had been leased to Healthscope.
Those properties were acquired from Medical Properties Trust in 2023 for about A$1.2 billion.
Healthcare Property Exposure
HMC Capital is an alternative asset manager with operations spanning real estate, private credit, private equity, energy transition and digital infrastructure.
The group manages approximately A$19.5 billion in Assets across its Investment platforms.
HealthCo represents an important part of HMC's healthcare real estate strategy. The Healthscope receivership created uncertainty because rental income from the affected properties was disrupted while a replacement operating structure was negotiated.
HealthCo agreed to rent deferrals during the process, increasing the importance of securing a viable long-term hospital operator.
What the Calvary Outcome Could Mean
A Calvary-led Takeover offers a pathway towards restoring more stable operating arrangements across the affected hospitals.
For HealthCo and HMC Capital (ASX:HMC), the central issue is whether new Lease agreements can establish reliable rental income under an operator with sufficient financial and operational capacity.
The development therefore represents an important step towards resolving a problem that has affected one of HMC's healthcare investment strategies.
However, the process is not complete. Regulatory approvals, final hospital transfers and execution of new leases still need to occur before the financial impact can be assessed with greater certainty.
Financial Impact
HealthCo reported funds from operations of 4.0 cents per unit for FY2026, compared with an underlying level of 7.7 cents per unit.
The difference was largely associated with disruption from the Healthscope situation.
HealthCo also provided FY2027 distribution guidance of around 6.0 cents per unit, subject to resolution of the hospital tenancy arrangements.
For HMC Capital, stabilisation of the healthcare portfolio could support management Earnings and improve visibility across a strategy that has faced operational uncertainty.
Broader Business Position
HMC Capital operates across several alternative asset classes rather than relying solely on healthcare property.
Its broader platforms include real estate, private credit, private equity, energy transition and digital infrastructure, giving the business multiple potential avenues for asset growth and fee generation.
Even so, the Healthscope situation has been significant because it affected a major healthcare property investment and highlighted the tenant concentration risks associated with hospital real estate.
A successful restructuring could allow management attention to shift back towards portfolio growth and capital deployment across its broader investment platform.
What Investors May Watch Next
The first issue to monitor is completion of the hospital transfers to the Calvary-led consortium.
Regulatory approvals and the precise terms of new lease arrangements will determine how quickly rental income can normalise.
Investors may also watch whether HealthCo confirms its FY2027 distribution guidance once greater certainty around the hospital portfolio is established.
Asset valuations across the affected properties will be another consideration, particularly if revised leases alter rental assumptions or long-term property economics.
For HMC Capital (ASX:HMC), progress in expanding assets under management across its other investment strategies will remain important alongside resolution of the healthcare portfolio.
Risks
The Calvary-led consortium's selection does not by itself guarantee an immediate restoration of full rental income.
Regulatory delays, lease negotiations or changes in hospital operating conditions could affect the timing and Economics of the transition.
Healthcare property also carries tenant concentration risk because hospital assets can be highly specialised and difficult to re-lease quickly if an operator encounters financial difficulties.
More broadly, HMC remains exposed to asset valuations, capital-market conditions, investor fund flows and performance across its managed investment platforms.
Key Takeaways
HMC Capital (ASX:HMC) has moved closer to resolving a major source of uncertainty across its healthcare property platform after a Calvary-led consortium was selected to take over Healthscope's hospital operations.
The development could provide a pathway towards more stable rental income for HealthCo and the associated HMC-managed fund that owns the hospital properties.
The next stage will depend on regulatory approvals, completion of hospital transfers and the terms of new leases. Those developments will determine how fully the Healthscope disruption can be put behind HMC's healthcare strategy.


_11_12_2026_12_24_48_733381.jpg)



Please wait processing your request...